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Abstract
Nowadays, the incidence of obesity is a global challenge and it is estimated that the total number of overweight and
obese adults will increase up to 1.35 billion by 2030. Evidence obtained from clinical and experimental studies shows
that obesity may be associated with cognitive performance and executive function impairments. Considering various
evidence for the poor episodic memory tasks and verbal learning as well as the destruction of cortical gray matter in the
obese individuals, here, we collected some causal pathways for contribution of inﬂammation, oxidative stress, insulin
resistance, and hypertension in the development of brain disorders in obesity. The present study focuses on the
providing an overview of the some negative effects of obesity on the brain. Different evidence mentioned in this review
has thrown light on the obesity-associated complications which may predispose obese people to brain damage, dementia, and Alzheimer's disease.
Keywords: Obesity, Brain damage, Inﬂammation, Oxidative stress, Insulin resistance, Hypertension

1. Introduction

O

besity is a prevalent disorder affecting children, adolescents and adults worldwide.
World Health Organization (WHO) has estimated
that 36.9% of male and 38.0% of female adults are
obese and overweight throughout the world. Also,
there are about 500 million obese and 2 billion
overweight individuals worldwide [1]. The potential
association of obesity with many health problems,
such as susceptibility to metabolic syndrome, insulin resistance (IR), type 2 diabetes mellitus (T2DM),
cardiovascular disease, hypertension, dyslipidemia
and cancers, is known [2,3].
Recently, some evidence has shown that there is a
negative relationship between the increase in the
body weight, body mass index (BMI) or waist

circumference and cognitive and executive functions [4]. Dementia is a clinical syndrome in which
mental functions such as memory, language, daily
life activities and psychosocial activities are progressively disturbed. Epidemiologic studies also
indicate that there is a link between obesity due to
fat consumption and an increased risk of Alzheimer's disease (AD), a subtype of dementia [5,6].
There is also a relationship between obesity and the
increased BMI, and whole-brain atrophy [7] and the
degradation of cortical gray matter [8,9]; the higher
the waist-to-hip ratio, the less the hippocampal
volume. People with a larger sagittal abdomen are
more likely to develop dementia [10,11]; dementia
was seen following obesity (BMI>30 kg/m2) and
overweight (BMI>25e30 kg/m2) at midlife [12].
Especially, mid-life central obesity is known as a
risk factor for future dementia [11]; the results of a
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meta-analysis study revealed that obesity increased
the AD risk in the elderly subjects [13].
The hippocampus is involved in the process of the
feeding behavior, as well as the modulation of
memory; its damage may impair learning, anterograde and retrograde memory [14,15]. Also, the
amygdala is a critical area involved in learning the
taste of food, guiding the appetitive behavior [16].
Evaluation of the brain structure in 527 20-87 yearold subjects, based on the analysis of the crosssectional magnetic resonance images, showed that
the degree of atrophy in the cerebral white-matter
volume of overweight and obese adults was greater
than that of the lean subjects [17]. Also, the results
obtained by magnetic resonance imaging (MRI)
have revealed that the volume of the amygdala and
hippocampus is increased in obese individuals [16];
however, the mechanisms behind this alteration
remain unknown. The memory and cognitive impairments associated with obesity, possibly due to
inﬂammation, gliosis and decreased gray matter of
the hippocampus, may lead to an increase in the
food intake by obese individuals because they are
unable to inhibit the activation of food-related
memories and the rewarding consequences of
eating [18]. Besides this, in the studies on obese
humans and experimental models, inﬂammation
and neuronal injury in the hypothalamus have been
observed [19].
All efforts concerning obesity management have
been focused on controlling chronic obesity-related
diseases like diabetes mellitus and cardiovascular
disease; however, other complications associated
with obesity and their inﬂuence on the brain function should also be taken into account. The present
review article, therefore, aims to highlight some
potential mechanisms and factors that may affect
the brain function over time in obesity. Here, we
have summarized the current knowledge to show
the adverse effects of oxidative stress, inﬂammation,
IR and hypertension associated with obesity on the
brain, as can be seen in Fig. 1.

2. Methodology
The authors searched the electronic literature for
the English-language articles; these were identiﬁed
by a series of Google scholar, PubMed, Web of
Sciences and Scopus searches using keywords such
as obesity, brain, inﬂammation, oxidative stress, IR,
hypertension or their equivalents, individually and/
or in different combinations published before
September 2020; the goal was to understand some
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potential mechanisms involved in the impairment of
the brain by obesity.

3. Results and discussion
3.1. Obesity: a low-grade inﬂammatory condition
Recent studies have considered obesity as a systemic and subclinical low-grade inﬂammatory condition. Adipose tissue contains adipocytes,
ﬁbroblasts, ﬁbroblastic pre-adipocytes, and endothelial and immune cells that secrete hormones and
cytokines [3]. The association between the presence
of the excess adipose tissue, especially the increased
white fat, and chronic inﬂammation, IR and the
levels of the endogenous sex steroids, leptin, visfatin
and plasminogen activator inhibitor-1 (PAI-1) is well
known [20]. Adipocytes can induce the production
of reactive oxygen species (ROS) by the activation of
immune cells; this, in turn, can augment the irregular production of adipokines and the inﬂammatory
status [3]. Also, it has been demonstrated that the
health risk of the increase in the intra-abdominal fat
depot (visceral or central obesity) is greater than
that of the subcutaneous accumulation of the excess
fat (peripheral obesity). Obesity, particularly central
obesity, may be a predictive condition for IR and
T2DM, which are among the important underlying
factors for inducing inﬂammation and development
of dementia [2].
3.1.1. Effects of inﬂammation on brain neurogenesis
During neurogenesis, neuroprogenitor cells proliferate and differentiate into neurons, astrocytes
and oligodendrocytes. Some studies have shown
that obesity may have impact on neurogenesis. In
this regard, a study of mice showed that a diet high
in fat impaired the neurogenic cells in the hypothalamus by the activation of the NF-kB pathway.
The high concentrations of cytokines in the bloodstream may inﬂuence neurogenesis; this is because
in some studies, the differentiation of neuroproggenitor cells in the presence of cytokines like
interleukin (IL)-1b, tumor necrosis factor-alpha
(TNF-a) and IL-6 has been shown to reduce their
neuronal markers, forcing them to differentiate into
a glial phenotype [21,22].
3.1.2. Effects of neuroinﬂammation on the feeding
behavior
The effects of neuroinﬂammation resulting from
obesity are seen in the hypothalamus, amygdala,
hippocampus, cortex and cerebellum [23,24].

M. GHOWSI ET AL
AVERSIVE EFFECTS OF OBESITY ON BRAIN

15
REVIEW ARTICLE

BioMedicine
2021;11(4):13e22

Fig. 1. A diagram representing some consequences of obesity on the brain.

Obesity caused by overconsuming high fat foods
interrupts the anorexigenic and thermogenic signals
produced by the hormones leptin and insulin,
inducing inﬂammation in the hypothalamic areas
which control the feeding behavior in the animals.
So, inﬂammation may impair neural circuits
involved in adjusting the balance between energy
intake and energy expenditure [25]. After eating
high-fat foods in mice, the expression of the inﬂammatory markers Il-6 and TNF-a, orexigenic
neuropeptides OReXine and agouti-related peptide
(AgRP) was increased; also, the inﬂammation in the
hypothalamus induced by the consumption of highfat diets was associated with the glial reaction. In the
long, medium or short term, the increased lipid
content in the diet caused inﬂammation in the hypothalamus; microglial cells and astrocytes are
involved in this inﬂammation. The disruption of the
hypothalamic functions by these inﬂammatory
conditions may expose people to the development
of obesity [26,27].
Cazettes et al. (2011) also showed that in overweight subjects, the increased concentration of
ﬁbrinogen, a marker of inﬂammation, was associated with an apparent elevation in the diffusion
coefﬁcient and interstitial ﬂuid in both amygdala
and right parietal cortex. These effects could damage the integrity of the microstructure of some regions of gray matter involved in the eating behavior
[28]. Interestingly, various studies on obesity have
established that hypothalamic inﬂammation is
developed and can be seen weeks before the
enlargement and inﬂammation of the adipose tissue, suggesting that the inﬂammation in the hypothalamus may be a noticeable factor in the
appearance of the visible obese phenotype; so, it is
not only a result of systemic inﬂammation [19,29,30].

Also, it has been reported that the prolonged
secretion of TNF-a by microglia in the MHB of the
mice fed a diet rich in fat or carbohydrates disrupted
the function of anorexigenic neurons producing
proopiomelanocortin, thus suggesting the contribution of hypothalamic microglia to the dietinduced obesity [30,31].
3.1.3. Role of inﬂammation in the pathogenesis of
neural diseases
Involvement of inﬂammatory cytokines in the
pathogenesis of neural diseases has been revealed
in various studies. In this regard, it has been shown
that in depression, inﬂammatory cytokines such as
IL-6 and TNF-a cause hypercortisolemia, which is
due to the stimulation of the adrenocorticotropic
hormone (ACTH) release. ACTH, in turn, induces
the apoptosis of neurons and decreases the number
of dendritic columns, synapses and glial cells population, causing dendritic atrophy [32]. In obesity,
inﬂammation damages the blood vessel integrity,
resulting in the inﬁltration of more inﬂammatory
cells into the cerebrospinal ﬂuid and perivascular
spaces in the brain [33]. Also, the inﬂammatory cytokines released from the adipose tissue and
entered into the bloodstream may damage cerebrovascular endothelial cells in the bloodebrain
barrier (BBB) [34]. In obesity, inﬂammation and inﬂammatory damage resulting from the production
of IL-6 and TNF-a in the adipose tissue can be
regarded as a central mechanism in the pathogenesis of Alzheimer's by damaging glia and neurons;
this is because these factors can cross the BBB and
enter the central nervous system. Also, moderate
inﬂammation caused by adiponectin can damage
the BBB. As obesity is increased, the production of
cortisol, estrogen, thyroid hormone, growth
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hormone, and insulin-like growth factor-1 (IGF-1) is
increased too. These hormones, insulin, and leptin
can affect the cognition, long-term potentiation
(LTP) and neuroprotection in the hippocampus.
Therefore, excess cortisol, probably due to excitotoxic glutamatergic neurotransmission, causes hippocampal atrophy and memory loss [13]. The
regions in the brain that are affected by inﬂammation are shown in Table 1.
An imbalance between production and clearance
of a protein named amyloid-b (Ab) is an early step
in the pathogenesis of AD. Accumulation of this
protein culminates during neuronal degeneration
and dementia [35]. In the brain, the amyloid deposition and other neuropathological processes that
cause dementia are associated with local inﬂammatory events such as the secretion of interleukin,
TNF-a, and other inﬂammatory factors [2]. Research
shows that in mice, the stimulation of the immune
system is associated with the deposition of the amyloid precursor protein (APP) and alteration in tau
phosphorylation [36]. Besides, AD patients suffer
from the high blood concentration of IL-6, TNF-a,
IL-1b, transforming growth factor-beta, IL-12 and
IL-8 [37].
3.2. Oxidative stress status in obesity
It is suggested that feeding a diet high in fat plays
a potential role in decreasing the antioxidant
response because it has been shown that feeding the
high-fat diet in the obesity models increases protein
oxidation and reduces cognitive performance in the
rodents. In this line, a study conducted on male
C57Bl/6 mice fed either ‘western diet’ (41% fat) or a
very high-fat lard diet (60% fat) for 16 weeks showed
that the latter increased adiposity, fasting blood
glucose and age-related protein carbonyl (a
biomarker of oxidative damage) in the hippocampus
and impaired retention in the behavioral test (Tmaze). This cognitive decline and oxidative stress
were associated with a reduction in Nuclear
Table 1. The brain areas inﬂuenced by inﬂammation during obesity
and/or use of a diet high in fat.
The brain regions inﬂuenced by inﬂammation

Reference

Hypothalamus, amygdala, hippocampus,
brain cortex and cerebellum
Blood vessel integrity and perivascular
spaces in the brain
Amygdala, right parietal cortex and the
areas in the gray matter involved in the
eating behavior
The hypothalamic area involved in the control
of the feeding behavior

[23,24]
[33]
[28]

[25]

Transcription Factor Erythroid 2eRelated Factor
(Nrf) 2 levels and Nrf2 activity [38].
3.2.1. Biochemical pathways in the induction of
oxidative stress in obesity
In the pentose phosphate pathway, as the main
pathway for the generation of NADPH, the glucose6-phosphate dehydrogenase (G6PD) enzyme is
involved in the metabolism of glucose to ribose-5phosphate; a decrease in its activity can result in a
reduction of NADPH production, thereby promoting oxidative stress [15]. Under high glucose conditions usually observed in obese individuals with
lower physical activity and overnutrition, the raised
activity of protein kinase A (PKA) could increase the
phosphorylation of G6PD; this, in turn, reduces the
production of NADPH, subsequently causing
oxidative stress [15,39]. The enzyme glutathione
reductase reduces glutathione disulﬁde (GSSG) to
an important free radical scavenger called glutathione. NADPH is needed for this activity. During
obesity, overnutrition and hyperglycemia may lead
to a decrease in the NADPH levels and a subsequent reduction of glutathione generation [15].
Some studies in AD have shown that the reduction
of cognitive functions is correlated with GSSG [40].
Also, glutathione depletion causes the induction of
apoptosis and oxidative toxicity due to the cytosolic
calcium overload in the hippocampus [41]. Thioredoxin (Trx) is a redox sensor protein reducing
oxidized proteins by an exchange of cysteine thioldisulﬁde. Based on this process, oxidized thioredoxin is reduced by NADPH [42]. In obese individuals, the higher levels of glucose and oxidative
stress can up-regulate the oxidative stress mediator
thioredoxin-interacting protein (TxNIP), which is an
inhibitor of thioredoxin. TxNIP may contribute to
the pathogenesis of AD because Ab can induce
TxNIP expression in vitro and the brains of the
5XFAD Alzheimer mice model [43]. Also, oxidative
stress can increase the expression of TxNIP, which
may lead to neurotoxicity [44].
3.2.2. Effects of oxidative stress on the development of
neurodegenerative disorders
Oxidative stress is one of the predisposing factors
contributing to the damage to brain tissues and
development of the central nervous system chronic
inﬂammatory and neurodegenerative disorders, like
AD, Huntington disease and Parkinson's disease, as
well as neuropsychiatric disorders such as anxiety
disorders and depression [45]. Also, chronic oxidative stress in obese people may play an axial role in
the onset of obesity-related neurodegenerative disorders because the resistance of the brain against

oxidative stress is lower than that of other organs
[46]. Oxidative stress causes neurodegeneration by
increasing ROS and lowering the antioxidant capacity [47]. In the brains of the patients with AD, the
activity of antioxidant enzymes SOD, catalase,
glutathione Peroxidase (GPx) and glutathione
reductase is reduced [48,49].
In obesity, the production of ROS may cause
oxidative damage to cellular molecules and cytoskeleton, contributing to the BBB. It has been suggested that in obesity, up-regulation of cytokines
and increased oxidative stress may damage the BBB
through the disruption of tight junctions and
augmentation of neuroinﬂammatory responses [50].
Oxidative stress may induce apoptosis and neurodegeneration in the brain [51]. Also, some studies
suggest oxidative stress may be among underlying
causes involved in the development of Parkinson's
disease. For example, in Parkinson's disease, the
excess accumulation of neurotoxic a-synuclein occurs and oxidative stress promotes a-synuclein aggregation in dopaminergic neurons. a-synuclein, in
turn, produces more intracellular ROS [52].
3.2.3. Vulnerability of the hippocampus and amygdala
to oxidative stress
Cerebellar granule cells, the hippocampus and
amygdala are involved in the behavioral and
cognitive deﬁcits; these areas are very vulnerable to
oxidative stress. In the hippocampus, the dentate
gyrus plays an important role in learning and
memory functions; the ventral hippocampus is
involved in anxiety and depression. Oxidative
stress, through alteration in the cell proliferation,
neurogenesis, capacity remodeling, and changes in
the structural plasticity, can impair the biochemical
integrity of the hippocampus and the amygdala, as
well as their functions; as a consequence, it may
disturb the normal synaptic neurotransmission [45].
The raised concentrations of ROS affect the longterm potentiation (LTP), synaptic signaling and
brain plasticity [53]. The increase in the ROS production could affect LTP by changing the N-methylD-aspartate (NMDA)-dependent calcium inﬂux. In
the CA1 synapses of the hippocampus, superoxide
acts as a signal in LTP and chronic oxidative stress is
a main reason for the decreased LTP response [54].
Also, obesity-related oxidative stress may impair
superoxide signaling in the hippocampal neurons
and the subsequent dysfunction of synapses may be
a reason for the impaired cognitive function in
obesity. Studies have also shown that the increased
concentrations of the advanced glycation end
products (AGEs) in the circulation and brain are
associated with cognitive dysfunctions in the old
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subjects with AD [55]. AGEs facilitate the formation
of amyloid plaques and increase the cytotoxicity of
Ab. Also, the expression of the AGE receptor, called
RAGE, is increased by AGEs, and RAGE may be a
receptor for Ab [21].
Oxidative stress may cause amygdalar hyperactivity and dendritic shrinking, which could further
exacerbate synaptic impairments by interrupting
the hippocampus-amygdala projections. Also, free
radicals may oxidize the extracellular sites of glutamatergic NMDA receptors, subsequently attenuating LTP and synaptic neurotransmission; this, in
turn, may result in behavioral and cognitive
impairment [45]. Also, in the brain, the increased
levels of free radicals may cause damage to cellular
structures such as membranes, DNA and cellular
proteins; it may change the activity of transcriptional factors such as NF-kB, thereby resulting in
chronic inﬂammation and cell apoptosis [56].
Although one study in male C57BL/6 mice showed
that the induction of obesity by high-fat diet during
a 7e8 month period increased the levels of ROS
parameters total ROS, superoxide and peroxynitrite
within the cerebral cortex, while decreasing the GPx
activity in the cerebral cortex, the serum concentrations of 8-Isoprostane, a biomarker of peripheral
oxidative stress, were not signiﬁcantly altered; the
results also showed that the elevation of ROS in the
brain were correlated with adiposity, but the increase in the ROS was not correlated with a cognitive decline in these models of obesity [57]. To
summarize, the experimental ﬁndings, as shown
above, suggest that in obese subjects, the oxidative
stress may be an axial mechanism for the development of various brain disorders and neural diseases
such as AD and dementia (Table 2).
3.3. The inﬂuence of IR on the brain functions
IR means a decrease in the ability of the insulin
receptor to respond to this hormone; as a result,
pancreatic beta cells begin to produce more insulin,
leading to hyperinsulinemia. Inﬂammatory factors
such as TNF-a, free fatty acid (FFA) and their
downstream factors such as amino-terminal c-Jun
kinases (JNK) are the most important linking factors
between obesity and IR [58].
About 80% of Alzheimer's patients have T2DM or
hyperglycemia. Animal models of diabetes also
show an association between abnormal glucose
metabolism, memory impairment and synaptic
plasticity disruption, suggesting that hyperglycemia
can impair cognitive functions [58].
Research also shows that the presence of the
excess insulin in the brain is associated with a
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Table 2. Summary of oxidative stress effects on the brain during obesitya.
The effects

Reference

Impairment of biochemical integrity in the hippocampus
and amygdala; alteration of structural plasticity, remodeling
capacity, and synaptic neurotransmission in the amygdala;
impairment of cell proliferation, neurogenesis in the amygdala
Inﬂuence on LTP and synaptic signaling
Damage to the cell membrane, DNA and proteins; induction of
chronic inﬂammation and cell apoptosis, and neurodegeneration
Hyperactivity of the amygdala and dendritic shrinking; synaptic
impairment in the amygdala
Oxidation of NMDA receptors and LTP and synaptic neurotransmission
in the amygdala
Damage to the BBB by the disruption of tight junctions and augmentation
of neuroinﬂammatory responses
Increase in the NMDA-dependent Calcium inﬂux and change in LTP
Increase in AGEs in the blood and brain that, in turn, facilitates the
formation of amyloid plaques and increases the cytotoxicity of Ab
Glutathione depletion causes cytosolic calcium overload, inducing
apoptosis and oxidative toxicity in the hippocampus
The up-regulation of TxNIP, which may cause an increase in the
oxidized proteins and neural death
Promotion of neurotoxic a-synuclein aggregation in dopaminergic
neurons involved in the development of Parkinson's disease

[45]

[53]
[51,56]
[45]
[45]
[50]
[54]
[21]
[41]
[42,43]
[52]

a

LTP - Long-term Potentiation, NMDA - N-Methyl-D-Aspartate, BBB - BloodeBrain-Barrier, AGEs - Advanced Glycation End
Products, Ab - Amyloid-b, TxNIP - Thioredoxin-interacting Protein.

reduction of cognitive impairment [58]; and hyperinsulinemia is a predisposing factor in the development of dementia, defects of insulin signaling,
and impairment of glucose metabolism in the brain.
It is suggested that hyperinsulinemia is related to
AD; so, the use of insulin in the AD patients improves the process of memory formation [59,60].
Various studies have shown the involvement of insulin in the growth of neurite, regulation of secretion, uptake of catecholamines, trafﬁcking of ligandcontaining ion channels, and modulation of synaptic
ﬂexibility through NMDA and PI3K/AKT. Also, insulin plays a crucial role in the formation and
maintenance of excitatory synapses and neural stem
cells activation [15,59]. This evidence suggests that
the obesity-induced IR may have a detrimental effect on brain functions.
3.3.1. The mechanisms linking the obesity associated
IR to the brain impairments
In the chronic peripheral IR and hyperinsulinemia
conditions, the decrease in the insulin transport
across the BBB is seen; this, in turn, decreases the
insulin concentration and its activity in the brain.
Various studies of AD patients have shown that in
their central nervous system, markers of brain insulin-signaling are decreased [58,61]. Also, in the
streptozotocin-induced diabetic mouse model, the
decreased brain insulin signaling was associated

with the increased phosphorylation of tau protein
and the increased Ab levels [62]. Besides this, using
a diet high in fat causes IR in the hypothalamus and
telencephalon, which is correlated to the defects of
synaptic plasticity, synaptic integrity and cognitive
behaviors [59,60]. On the other hand, obesity and
T2DM are two predicting factors for cardiovascular
diseases that may impair cognitive performance by
reducing the cerebral blood ﬂow in the cerebrum
[2]. Moreover, in obesity, the transport of insulin
across the BBB is decreased [63,64].
In one study, a mouse model of obesity was
developed by treating mice with a diet high in fat
and sugar (fructose and sucrose); the results showed
that this diet reduced the expression of glucose
transporter (GLUT) 1, GLUT3, and the insulindegrading enzyme in the brain of the mice models,
as compared to the controls. Considering the role of
the insulin-degrading enzyme in the degradation of
Ab, their results imply that the degradation and
clearance of Ab were decreased [59]. The Ab oligomers toxicity directly induces neuronal resistance to
insulin and inhibits LTP [58].
On the other hand, the chronic overactivation of
AKT by IR may lead to the hyperphosphorylation of
AMPK Ser485 and the subsequent inhibition of Tau
dephosphorylation. Hyperphosphorilation of Tau
decreases its solubility; therefore, it cannot assemble
tubulins for the formation of microtubules and

vesicular transport, resulting in neurodegeneration
[59]. In a mice model of obesity, AKT and AMPK
Ser485 were hyperactivated in comparison to controls [59]. As mentioned previously, activation of
PKA can impair synaptic activity through phosphorylation of the tau protein [15].
One membrane-associated scaffolding protein,
called PSD-95, is an important regulator of synaptic
strength. The results of a study showed that PSD-95
gene expression was decreased in obese mice, as
compared to the control ones [59]. Ser phosphorylation of insulin receptor substrate-1 (IRS-1) resulted in the inhibition of the IRS-1 activity and the
subsequent IRS-1 degradation. Another study also
showed that the high-fat and sugar diet induced IR
in the neurons by decreasing the tyrosine phosphorylation of IRS-1 and increasing IRS-1 serine
phosphorylation. Further, these were associated
with the activation of stress (JNK and CHOP) and
inﬂammatory pathways (NFkB) in the brains of animals [59]. Also, oxidative stress plays a central role
in IR [65]. Oxidative stress and inﬂammatory cytokines cause the increase in the IRS-1 and Akt serine
phosphorylation, leading to the decrease in the insulin receptor expression and tyrosine phosphorylation, which can augment IR [58]. Therefore, in
obesity, oxidative stress and inﬂammation can
induce the brain IR. To summarize, during obesity,
the IR induced by oxidative stress and inﬂammation
may be one of the important factors which could
impair the hippocampal functions, thus contributing
to the development of neurodegenerative diseases
like AD.
3.4. The obesity induced-hypertension
Various clinical and animal studies have reported
that obesity, especially visceral obesity, is among
factors contributing to developing hypertension and
cardiovascular diseases [66,67]. The obese people
are more likely to have high blood pressure and
arterial stiffness; it has been shown that the systolic
and diastolic blood pressure, and pulse wave velocity (PWV) in the obese subjects are increased, in
comparison to the normal weight people. Obesity
increases the intravascular inﬂammation, altering
the endothelial function, increasing the thickness of
the intima-media and reducing the lumen diameter
of arteries [68]. Moreover, there is much evidence
suggesting that obesity, through different mechanisms such as activation of the renin-angiotensinaldosterone system, the raised sympathetic activity,
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IR, leptin resistance, the increased coagulation activity, endothelial dysfunction and enhanced renal
sodium reabsorption, raises the blood pressure [69].
3.4.1. The effects of hypertension induced by obesity
on the brain
One of the mechanisms suggested for the association between obesity and the increased risk of dementia is hypertension; some studies suggest that
obese people are disposed to hypertension and hypertensive people are disposed to dementia; hypertension is an independent risk factor for AD
[66,67,70]. Various epidemiological studies show
that high blood pressure and cerebrovascular diseases in middle age are associated with cognitive
defects and dementia, especially AD and vascular
dementia [71,72].
The evidence obtained from magnetic resonance
imaging suggests that high blood pressure can affect
the brain; however, the underlying mechanisms of
the effects of high blood pressure on the brain and
the association of high blood pressure with AD are
unclear [73]. In this regard, a study of 3735 JapaneseAmerican men in Hawaii found that the increased
systolic blood pressure (BP) at the middle age might
be a predictor of a future cognitive decline. Their
ﬁndings also showed that a 10 mm Hg rise in the
systolic BP could be associated with the decreased
cognitive function [74]. Also, a study of a sample of
Japanese-American men born between 1900 and
1919 examined the association between middleaged BP and the late hippocampal atrophy, showing
that people with high systolic BP were at risk for
hippocampal atrophy [14].
Also, one study examined the relationship between BMI and the higher systolic and diastolic
blood pressure and the decreased motor function
and agility, and executive performance tests; the
obtained results showed that there was a negative
relationship between total and central obesity and
cognitive function [75]. In addition, the MRI studies
have shown that hypertensive people have
damaged brain white matter and periventricular
white matter [76]. Also, in these patients, the alteration in the vascular structure and vascular tone
could cause tissue hypoxia and increase the
bloodebrain barrier permeability [77].
3.4.2. The mechanisms underlying the relationship
between the effects of hypertension on the brain
In the brains of the patients with vascular dementia, the inﬁltration of plasma constituents and

REVIEW ARTICLE

BioMedicine
2021;11(4):13e22

20

M. GHOWSI ET AL
AVERSIVE EFFECTS OF OBESITY ON BRAIN

REVIEW ARTICLE

inﬂammatory cells into the arterial walls and the
surrounding vascular tissue can lead to atherosclerosis, ﬁbrinoid necrosis, lipohyalinosis, endothelial
dysfunction, and BBB breakdown. Endothelial
dysfunction and inﬂammation may thicken the
arterial wall, thus increasing the risk of ischemia.
Moreover, in these cases, the ability to expand the
damaged arterial walls is limited [5].
The cerebral blood ﬂow is synchronized with cerebral activity. Hypertension through the improper
regulation of vasoactive mediators including nitric
oxide (NO) and endothelin-1, induction of oxidative
stress, blood vessels restructuring, and inadequate
brain readjustment may affect this process, leading to
vascular dementia [78]. Under hypertensive conditions, the inﬂammatory response induced by neuroglial cells and the stimulation of metalloproteinase 9
production by oligodendrocytes can have destructive
effects on the BBB; also, in the arteries of this region,
the ﬁbrohyaline deposition and atherosclerosis occur
[79]. In some cases, there is a loss of vascular wall
integrity and a large amount of hyaline deposit [80].
Besides this, evidence obtained from models linking
hypertension to the cognitive function suggests that
silent clinical stroke, metabolic imbalance, the altered
distribution of cerebral blood ﬂow, demyelination or
microinfarction of the white matter of the brain may
be among the pathways linking high blood pressure
to the risk of cognitive impairment; many of these
conditions are seen in obesity [81]. To sum it up, in the
obese subjects, the high blood pressure may increase
the risk of cognitive impairment and dementia
without stroke [73].

4. Conclusions
By considering the factors discussed previously, it
is likely that the consequences of obesity on brain
functions are mediated by oxidative stress, inﬂammation and hypertension; these factors, when
associated with obesity, make people vulnerable to
stroke, dementia and AD. Therefore, management
of obesity by different approaches like caloric restriction, regular physical activity and pharmacological treatments may be particularly important for
the prevention of neural disorders such as dementia
and AD. Considering the growing obese and overweight population worldwide, it is likely that the
health care systems may be facing subtle executive
dysfunction and cognitive decline in the future.
Awareness obtained from studies of the brain
complications associated with obesity and/or a highfat diet can result in the development of new ways to
postpone cognitive dysfunction. However, a
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complex set of reciprocal actions are involved in the
effect of obesity on brain health; so, more research is
needed to describe the exact link between the effects
of obesity and overweight and impaired brain
functions.
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